Skip to main content
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1986 Jun;96(3):483–489. doi: 10.1017/s0022172400066286

Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens

Pravan Suntharasamai, Pornthep Chanthavanich, M J Warrell, Sornchai Looareesuwan, Juntra Karbwang, Wichai Supanaranond, R E Phillips, Weerapol Jansawan, C Xueref, X Pouradier-Duteil, D A Warrell
PMCID: PMC2129681  PMID: 3734433

Abstract

Neutralizing antibody responses to conventional rabies post-exposure regimens of human diploid cell strain vaccine (HDCSV) and the new purified Vero cell rabies vaccine (PVRV) were compared in 58 healthy Thai veterinary students. The geometric mean titres (GMTs) of the group given HDCSV were slightly higher than those given PVRV, but on day 28 the peak GMTs of the two groups were statistically similar. The early antibody response to PVRV was unaffected by the addition of passive immunization, whereas the level of HDCSV response was reduced on day 14, so that there was no difference on that day between the GMTs of the two vaccine groups given HRIG. However, by day 91 the GMT of those given PVRV and HRIG was lower than in those given HDCSV alone or with HRIG. The appearance of antibody was less rapid than was observed in previous studies using multiple-site intradermal vaccination. Side effects were trivial. Our results confirm the promise of this new, potentially more economical tissue culture vaccine, but they suggest that the regimen could be improved.

Full text

PDF
483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lemon S. M., Miller R. N., Pang L. W., Prier R. E., Bernard K. W. Failure to achieve predicted antibody responses with intradermal and intramuscular human diploid cell rabies vaccine. Lancet. 1984 May 19;1(8386):1098–1100. doi: 10.1016/s0140-6736(84)92509-1. [DOI] [PubMed] [Google Scholar]
  2. Plotkin S. A. Rabies vaccine prepared in human cell cultures: progress and perspectives. Rev Infect Dis. 1980 May-Jun;2(3):433–448. doi: 10.1093/clinids/2.3.433. [DOI] [PubMed] [Google Scholar]
  3. Thongcharoen P., Wasi C. Possible factors influencing unsuccessful protection of post-exposure prophylaxis for rabies by human diploid cell vaccine. J Med Assoc Thai. 1985 Jul;68(7):386–387. [PubMed] [Google Scholar]
  4. Warrell M. J., Nicholson K. G., Warrell D. A., Suntharasamai P., Chanthavanich P., Viravan C., Sinhaseni A., Chiewbambroongkiat M. K., Pouradier-Duteil X., Xueref C. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet. 1985 May 11;1(8437):1059–1062. doi: 10.1016/s0140-6736(85)92367-0. [DOI] [PubMed] [Google Scholar]
  5. Warrell M. J., Suntharasamai P., Nicholson K. G., Warrell D. A., Chanthavanich P., Viravan C., Sinhaseni A., Phanfung R., Xueref C., Vincent-Falquet J. C. Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens. Lancet. 1984 Apr 21;1(8382):874–876. doi: 10.1016/s0140-6736(84)91340-0. [DOI] [PubMed] [Google Scholar]
  6. Warrell M. J., Warrell D. A., Suntharasamai P., Viravan C., Sinhaseni A., Udomsakdi D., Phanfung R., Xueref C., Vincent-Falquet J. C., Nicholson K. G. An economical regimen of human diploid cell strain anti-rabies vaccine for post-exposure prophylaxis. Lancet. 1983 Aug 6;2(8345):301–304. doi: 10.1016/s0140-6736(83)90288-x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES